Hypertension
Conditions
Brief summary
Epidemiological study (cross-sectional study) in order to determine the patients who present an adequate control of the Blood Pressure (BP), in a population of Colombian patients diagnosed with Arterial Hypertension (AH) and who are under pharmacological treatment.
Detailed description
OBJECTIVE: To determine the proportion of patients who present an adequate control of the Blood Pressure (BP), in a population of Colombian patients diagnosed with Arterial Hypertension (AH) and who are under pharmacological treatment. MATERIALS AND METHODS: Epidemiological study (cross-sectional study), multicentre type, in patients older than 18 years with prior diagnosis of AH in Colombia. The blood pressure control will be evaluated as the main variable (only one single blood pressure check in the doctor's office). Other secondary variables to evaluate are: demographical analysis, type (s) of antihypertensive treatment (s) used in patients, level of BP control, adverse events associated with antihypertensive treatment, comorbidities and risk factors, adherence, perception about the possible benefits of the use of combined therapy in mono-tablet versus multi-tablet. The analysis will be carried out from two perspectives: A first descriptive approach and a second analytical approach, with a level of significance of 5%.
Interventions
None listed
Sponsors
Scandinavia Pharma
Study design
Observational model
OTHER
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age ≥ 18 years * Prior diagnosis of Arterial Hypertension (AH) ≥ 3 months before * Patients who are under pharmacological treatment of AH ≥ 3 months before
Exclusion criteria
* The patient has rejected the participation in the study. * Patients who, in the judgment of the Investigator, do not understand or are not willing to adequately answer the questions. * Mental or psychiatric illness that, in the judgment of the investigator, does not allow adequate information to be obtained.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Patients with adequate control of the Blood Pressure (BP) | It will be evaluated in each patient (only once, at the time of the interview) throughout the study which is estimated to last 3 years. | Proportion of patients who present an adequate control of the Blood Pressure (BP) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Demographic analysis | It will be evaluated in each patient (only once, at the time of the interview) throughout the study which is estimated to last 3 years. | Characterization of patients |
| Treatment analysis | It will be evaluated in each patient (only once, at the time of the interview) throughout the study which is estimated to last 3 years. | Characterization of treatment (s) used |
| Personal history of diseases | It will be evaluated in each patient (only once, at the time of the interview) throughout the study which is estimated to last 3 years. | Evaluation of personal history of diseases |
| Adverse Events related with the treatment | It will be evaluated in each patient (only once, at the time of the interview) throughout the study which is estimated to last 3 years. | Adverse events associated with the treatment (s) |
Countries
Colombia
Contacts
Primary ContactJavier Castillo, Dr
Backup ContactFerrari Claudio, Dr
Outcome results
None listed